Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 3.1B | 3.2B | 3.2B |
Cost of revenue | 2.0B | 1.9B | 2.1B | 2.0B |
Gross profit | 1.1B | 1.2B | 1.2B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 629M | 646M | 720M | 668M |
Other operating expenses | — | — | — | — |
Operating income | 430M | 531M | 456M | 493M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 63M | 70M | 75M | 83M |
Other income expense | 11M | -110M | 21M | 33M |
Pretax income | 378M | 456M | 402M | 443M |
Tax provision | 73M | 91M | 34M | 97M |
Net income | 308M | 368M | 370M | 347M |
Basic EPS | 0.9 | 1.1 | 1.1 | 1.0 |
Diluted EPS | 0.9 | 1.0 | 1.1 | 1 |
Basic average shares | 346M | 345M | 343M | 342M |
Diluted average shares | 349M | 350M | 347M | 345M |
EBITDA | 533M | 620M | 569M | 621M |
Net income from continuing op. | 308M | 368M | 370M | 347M |
Minority interests | -4M | -3M | -3M | -3M |
Preferred stock dividends | — | — | — | — |